- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05269303
Wearable Monitoring Device in Daily Lives of Community-dwelling Older Adults
September 20, 2023 updated by: Arkers, Wong, The Hong Kong Polytechnic University
Optimizing the Health-related Functions of a Wearable Monitoring Device in the Daily Life of Community-dwelling Older Adults: A Randomized Pilot Study
The aim is to implement an intervention program to promote the continued use of Wearable Monitoring Devices among older adults through a peer support approach facilitating the incorporation of Wearable Monitoring Devices in daily life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hong Kong, Hong Kong
- Siu Sai Wan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- aged 60 or above
- own a smartphone
- able to communicate in Cantonese or Mandarin
- able to access the Internet at home or elsewhere
Exclusion Criteria:
- have a confirmed diagnosis of cognitive impairment
- bed-bound
- currently own a wearable monitoring device
- have already engaged in other wearable device studies
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Participants will receive a 3-month Live With Wearable Monitoring Device program.
|
The participants in the intervention group will receive a home visit by a Community Healthcare Worker in the first month, and biweekly motivational messages via Whats App in the second and third months.
|
|
No Intervention: Control group
Usual care.
As with the participants in the intervention group, those in the control group can utilize the features in the Wearable Monitoring Device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change of use intention of wearable monitoring device
Time Frame: Data collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
|
It will be measured using a 4-item, 5-point Likert scale adopted from Bhattacherjee (2001) and Windasari et al. (2021).
The five-point scale ranges from 1 = not at all satisfied to 5 = very certain, with higher scores representing a higher chance of continuing to use the WMD.
|
Data collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change of adherence rate of wearing wearable monitoring device
Time Frame: Data collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
|
It will be measured by checking in our database the number of days that participants wore their device, and the average amount of time worn per day.
Longer time worn represents better adherence rate
|
Data collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
|
|
The change in quality of life among baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
Time Frame: baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
|
Quality of life will be measured using the Hong Kong version of the EuroQol 5-dimension scale.
The EQ-5D-5L is comprised of five dimensions, namely, mobility, self-care, usual activities, pain or discomfort, and anxiety or depression.
The utility score ranges from 0 to 1, with higher means better quality of life
|
baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
|
|
The change of health service utilization among baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
Time Frame: baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
|
ealth service utilization includes the number of attendances at a general practitioner's office, emergency department, hospital, and general out-patient clinic.
The data will be reported by the participants and confirmed with medical and attendance certificates
|
baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
|
|
Recruitment rate
Time Frame: baseline pre-intervention
|
The recruitment rate will be calculated by dividing the number of participants who are recruited and randomized, by the number of eligible participants.
|
baseline pre-intervention
|
|
Attrition rate
Time Frame: 6-month (T3) time points
|
The attrition rate refers to the number of participants who withdraw from the study or who are lost to follow up.
|
6-month (T3) time points
|
|
Incidence of reports of adverse events
Time Frame: 6-month (T3) time points
|
the incidence of reports of adverse events will be recorded by a staff member assigned to each of the community centres and a nurse
|
6-month (T3) time points
|
|
Incidence of reports of technical difficulties
Time Frame: 6-month (T3) time points
|
Incidence of reports of technical difficulties will be recorded by a staff member assigned to each of the community centres and a nurse
|
6-month (T3) time points
|
|
The change of perceived usability of the wearable monitoring device before and after the program
Time Frame: baseline pre-intervention, 6-month (T3) time points
|
The participants will be required to complete a questionnaire that measures their attitude towards using the WMD; the perceived usefulness, perceived ease of use, and self-efficacy of using the device; and their level of anxiety about using the device.
The questionnaire was drawn up by Chen and Chan (2014).
This 10-point Likert scale ranges from 1 (strongly disagree) to 10 (strongly agree), with higher marks indicating a better outcome, with the exception of the item on anxiety levels, where higher marks represent a higher level of anxiety in using the WMD.
|
baseline pre-intervention, 6-month (T3) time points
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Arkers Wong, Ph.D., The Hong Kong Polytechnic University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 10, 2022
Primary Completion (Actual)
July 9, 2023
Study Completion (Actual)
July 9, 2023
Study Registration Dates
First Submitted
February 24, 2022
First Submitted That Met QC Criteria
March 3, 2022
First Posted (Actual)
March 7, 2022
Study Record Updates
Last Update Posted (Actual)
September 22, 2023
Last Update Submitted That Met QC Criteria
September 20, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- A001523
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Device Ineffective
-
Children's Hospital of PhiladelphiaTerminatedDevice Ineffective | Device Induced InjuryUnited States
-
Institut Cancerologie de l'OuestCompleted
-
Guang'anmen Hospital of China Academy of Chinese...Completed
-
Milton S. Hershey Medical CenterWithdrawnSafety Issues | Device Dislodgement | Device Intolerance | Device Ineffective
-
Lancaster General HospitalWithdrawn
-
University of GeorgiaCompletedIneffective ErythropoiesisUnited States
-
First Affiliated Hospital of Chongqing Medical...UnknownIneffective Airway Clearance | Respiratory Tract HemorrhageChina
-
Schulthess KlinikCompletedDevice Success Rate | Device PerformanceSwitzerland, Austria
-
IWK Health CentreNot yet recruitingMedical Device | Aerosol Generating Procedure | Medical Device PerformanceCanada
-
University of Kansas Medical CenterCompletedFemale Contraception | Women's Health | Reproductive Health | Intrauterine Device Complications | Contraceptive Device Failure | IUD Fragmentation | Retained Intrauterine DeviceUnited States
Clinical Trials on Live With Wearable Monitoring Device program
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Kuopio University HospitalUniversity of Eastern FinlandRecruitingAtrial Fibrillation | Heart Rate Fast | Heart Rate Low | Sinus RhythmFinland
-
Johns Hopkins UniversityTerminatedCongenital Heart Disease in ChildrenUnited States
-
Nanowear Inc.CompletedPulmonary Disease, Chronic Obstructive | Blood Pressure | Heart Rhythm Disorder | Heart Disease ChronicUnited States
-
Vilnius UniversityKaunas University of TechnologyCompletedAtrial FibrillationLithuania
-
Czech Technical University in PragueEnrolling by invitationRespiratory Rate MonitoringCzechia
-
Zoll Medical CorporationNot yet recruitingHeart FailureNetherlands, Sweden, Spain, Italy, France, United Kingdom, Switzerland, Germany, Poland
-
Peking University Third HospitalNot yet recruitingBenign Prostatic HyperplasiaChina
-
Seoul National University Bundang HospitalMinistry of SMEs and Startups, Korea; Exosystems CO.,LtdTerminatedAnterior Cruciate Ligament ReconstructionKorea, Republic of
-
The University of Hong KongRecruitingExercise | Fitness Trackers | Cardio Vascular Disease | Physical Activities | Health CoachingHong Kong